Vanda Pharmaceuticals Inc... (VNDA)

VNDA trades at $5.43, 8.6% above the near-term max pain of $5 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($2-$5), reflecting growing call interest at higher strikes. Key magnetic zone at 5 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for VNDA shows an upward trend from 2 to 5, suggesting bullish positioning in longer-dated options. The 75% spread signals divergent expectations across timeframes. Most levels below 5.43 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.